{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T16:11:15Z","timestamp":1784823075690,"version":"3.55.0"},"reference-count":50,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,11,27]]},"DOI":"10.1097\/tp.0b013e3181ba07ec","type":"journal-article","created":{"date-parts":[[2009,11,22]],"date-time":"2009-11-22T03:15:55Z","timestamp":1258859755000},"page":"1186-1193","source":"Crossref","is-referenced-by-count":50,"title":["Blood Group O Recipients Associated With Early Graft Deterioration in Living ABO-Incompatible Kidney Transplantation"],"prefix":"10.1097","volume":"88","author":[{"given":"Daisuke","family":"Toki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Ishida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeru","family":"Horita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutaka","family":"Yamaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazunari","family":"Tanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-7-20210211","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1097\/00007890-199801270-00014","article-title":"Long-term results of ABO-incompatible living kidney transplantation: A single-center experience.","volume":"65","author":"Tanabe","year":"1998","journal-title":"Transplantation"},{"key":"R2-7-20210211","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/S0094-0143(01)80032-X","article-title":"Long-term outcome of ABO-incompatible renal transplantation.","volume":"28","author":"Toma","year":"2001","journal-title":"Urol Clin North Am"},{"key":"R3-7-20210211","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1097\/00007890-200109150-00033","article-title":"Time-dependent risk factors influencing the long-term outcome in living renal allografts: Donor age is a crucial risk factor for long-term graft survival more than 5 years after transplantation.","volume":"72","author":"Toma","year":"2001","journal-title":"Transplantation"},{"key":"R4-7-20210211","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1007\/s10157-007-0461-z","article-title":"Recent findings in ABO-incompatible kidney transplantation: Classification and therapeutic strategy for acute antibody- mediated rejection due to ABO-blood-group-related antigens during the critical period preceding the establishment of accommodation.","volume":"11","author":"Takahashi","year":"2007","journal-title":"Clin Exp Nephrol"},{"key":"R5-7-20210211","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1172\/JCI106094","article-title":"Blood group isoantibody stimulation in man by feeding blood group-active bacteria.","volume":"48","author":"Springer","year":"1969","journal-title":"J Clin Invest"},{"key":"R6-7-20210211","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1111\/j.1423-0410.1984.tb01590.x","article-title":"Response to immunization with A and B human glycoproteins for the procurement of blood grouping reagents.","volume":"47","author":"Contreras","year":"1984","journal-title":"Vox Sang"},{"key":"R7-7-20210211","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1136\/jcp.39.6.684","article-title":"Distribution of immunoglobulin G subclasses in anti-A and anti-B sera.","volume":"39","author":"Kay","year":"1986","journal-title":"J Clin Pathol"},{"key":"R8-7-20210211","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/S0002-9610(05)81197-3","article-title":"Current experience with renal transplantation across the ABO barrier.","volume":"164","author":"Nelson","year":"1992","journal-title":"Am J Surg"},{"key":"R9-7-20210211","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1111\/j.1365-2141.2005.05705.x","article-title":"Isotype-specific detection of ABO blood group antibodies using a novel flow cytometric method.","volume":"130","author":"Stussi","year":"2005","journal-title":"Br J Haematol"},{"key":"R10-7-20210211","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1111\/j.1600-6143.2007.01750.x","article-title":"Long-term survival of kidneys transplanted from live A2 donors to O and B recipients.","volume":"7","author":"Bryan","year":"2007","journal-title":"Am J Transplant"},{"key":"R11-7-20210211","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1097\/TP.0b013e31817c4c4c","article-title":"Application of flow cytometry to monitor antibody levels in ABO incompatible kidney transplantation.","volume":"86","author":"Krishnan","year":"2008","journal-title":"Transplantation"},{"key":"R12-7-20210211","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1172\/JCI104322","article-title":"Isoagglutinins associated with ABO erythroblastosis.","volume":"40","author":"Kochwa","year":"1961","journal-title":"J Clin Invest"},{"key":"R13-7-20210211","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/S0140-6736(88)90466-7","article-title":"What is the best predictor of the severity of ABO-haemolytic disease of the newborn?","volume":"2","author":"Brouwers","year":"1988","journal-title":"Lancet"},{"key":"R14-7-20210211","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1097\/00007890-200011150-00011","article-title":"Role of anti-A\/B antibody titers in results of ABO-incompatible kidney transplantation.","volume":"70","author":"Shimmura","year":"2000","journal-title":"Transplantation"},{"key":"R15-7-20210211","article-title":"Guidelines for antibody incompatible transplantation.","year":"2006","journal-title":"The British Transplantation Society"},{"key":"R16-7-20210211","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/hep.21928","article-title":"Present status of ABO-incompatible living donor liver transplantation in Japan.","volume":"47","author":"Egawa","year":"2008","journal-title":"Hepatology"},{"key":"R17-7-20210211","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1016\/j.transproceed.2004.08.142","article-title":"Excellent outcome of ABO-incompatible living kidney transplantation under pretransplantation immunosuppression with tacrolimus, mycophenolate mofetil, and steroid.","volume":"36","author":"Tanabe","year":"2004","journal-title":"Transplant Proc"},{"key":"R18-7-20210211","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1111\/j.1600-6143.2006.01676.x","article-title":"Evaluation of immunosuppressive regimens in ABO-incompatible living kidney transplantation-single center analysis.","volume":"7","author":"Ishida","year":"2007","journal-title":"Am J Transplant"},{"key":"R19-7-20210211","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1034\/j.1600-6143.2003.00072.x","article-title":"Antibody-mediated rejection criteria\u2014An addition to the Banff 97 classification of renal allograft rejection.","volume":"3","author":"Racusen","year":"2003","journal-title":"Am J Transplant"},{"key":"R20-7-20210211","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1046\/j.1600-6135.2003.00278.x","article-title":"Histologic findings of antibody- mediated rejection in ABO blood-group-incompatible living-donor kidney transplantation.","volume":"4","author":"Fidler","year":"2004","journal-title":"Am J Transplant"},{"key":"R21-7-20210211","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1111\/j.1600-6143.2004.00500.x","article-title":"National conference to assess antibody-mediated rejection in solid organ transplantation.","volume":"4","author":"Takemoto","year":"2004","journal-title":"Am J Transplant"},{"key":"R22-7-20210211","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1111\/j.1600-6143.2008.02159.x","article-title":"Banff 07 classification of renal allograft pathology: Updates and future directions.","volume":"8","author":"Solez","year":"2008","journal-title":"Am J Transplant"},{"key":"R23-7-20210211","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1097\/00007890-198912000-00011","article-title":"Characterization of lymphocytotoxic antibodies causing a positive crossmatch in renal transplantation. Relationship to primary and regraft outcome.","volume":"48","author":"Taylor","year":"1989","journal-title":"Transplantation"},{"key":"R24-7-20210211","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1111\/j.1399-0012.1997.tb01042.x","article-title":"IgM antibodies in renal transplantation.","volume":"11","author":"McCalmon","year":"1997","journal-title":"Clin Transplant"},{"key":"R25-7-20210211","first-page":"394","article-title":"Immunoglobulin M antibodies in transplanted human hearts.","volume":"12","author":"Labarrere","year":"1993","journal-title":"J Heart Lung Transplant"},{"key":"R26-7-20210211","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1097\/00007890-199901270-00012","article-title":"The role of flow cytometry-detected IgG and IgM anti-donor antibodies in cardiac allograft recipients.","volume":"67","author":"Przybylowski","year":"1999","journal-title":"Transplantation"},{"key":"R27-7-20210211","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/lt.20062","article-title":"Protective anti-donor IgM production after crossmatch positive liver-kidney transplantation.","volume":"10","author":"McAlister","year":"2004","journal-title":"Liver Transpl"},{"key":"R28-7-20210211","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1097\/00007890-199912270-00007","article-title":"Flow cytometry-detected IgG is not a contraindication to renal transplantation: IgM may be beneficial to outcome.","volume":"68","author":"Kerman","year":"1999","journal-title":"Transplantation"},{"key":"R29-7-20210211","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1097\/01.tp.0000185193.77929.96","article-title":"Differences in humoral immunity between a non-rejection group and a rejection group after ABO- incompatible renal transplantation.","volume":"81","author":"Ishida","year":"2006","journal-title":"Transplantation"},{"issue":"suppl 11","key":"R30-7-20210211","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.1399-0012.2004.00241","article-title":"C4d and\/or immunoglobulins deposition in peritubular capillaries in perioperative graft biopsies in ABO-incompatible renal transplantation.","volume":"18","author":"Kanetsuna","year":"2004","journal-title":"Clin Transplant"},{"key":"R31-7-20210211","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.1093\/ndt\/gfl210","article-title":"Immunohistochemical evidence of activated lectin pathway in kidney allografts with peritubular capillary C4d deposition.","volume":"21","author":"Imai","year":"2006","journal-title":"Nephrol Dial Transplant"},{"key":"R32-7-20210211","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1111\/j.1600-6143.2006.01356.x","article-title":"C4d and C3d staining in biopsies of ABO- and HLA-incompatible renal allografts: Correlation with histologic findings.","volume":"6","author":"Haas","year":"2006","journal-title":"Am J Transplant"},{"key":"R33-7-20210211","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/j.1600-6143.2007.02036.x","article-title":"Analysis of renal transplant protocol biopsies in ABO-incompatible kidney transplantation.","volume":"8","author":"Setoguchi","year":"2008","journal-title":"Am J Transplant"},{"key":"R34-7-20210211","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1093\/ndt\/gfn478","article-title":"ABO blood group-incompatible living donor kidney transplantation: A prospective, single-centre analysis including serial protocol biopsies.","volume":"24","author":"Oettl","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"R35-7-20210211","first-page":"95","article-title":"Xenotransplantation, 2nd ed.","author":"Galili","year":"1997"},{"key":"R36-7-20210211","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1023\/A:1020506617105","article-title":"Immunochemical properties of anti-Gal alpha 1-3Gal antibodies after sensitization with xenogeneic tissues.","volume":"19","author":"Yu","year":"1999","journal-title":"J Clin Immunol"},{"key":"R37-7-20210211","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1172\/JCI7358","article-title":"Differential immune responses to alpha-gal epitopes on xenografts and allografts: Implications for accommodation in xenotransplantation.","volume":"105","author":"Tanemura","year":"2000","journal-title":"J Clin Invest"},{"key":"R38-7-20210211","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/S0140-6736(03)14118-9","article-title":"Clinical xenotransplantion\u2013How close are we?","volume":"362","author":"Cooper","year":"2003","journal-title":"Lancet"},{"key":"R39-7-20210211","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1016\/S0140-6736(84)92061-0","article-title":"Cellular basis of immune response to antigens of ABO blood-group system. Capacity to provide help during response to T-cell- dependent ABO-system antigens is restricted to individuals of blood group O.","volume":"2","author":"Kay","year":"1984","journal-title":"Lancet"},{"key":"R40-7-20210211","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1097\/00007890-200112150-00007","article-title":"Pig kidney transplantation in baboons: Anti-Gal(alpha)1-3Gal IgM alone is associated with acute humoral xenograft rejection and disseminated intravascular coagulation.","volume":"72","author":"B\u00fchler","year":"2001","journal-title":"Transplantation"},{"key":"R41-7-20210211","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1097\/01.tp.0000296030.88283.92","article-title":"The role of graft and host accommodation in a hamster-to-rat cardiac transplantation model.","volume":"85","author":"Komori","year":"2008","journal-title":"Transplantation"},{"key":"R42-7-20210211","doi-asserted-by":"crossref","first-page":"4567","DOI":"10.1182\/blood-2007-04-082719","article-title":"The persistent elimination of B cells responding to blood group A carbohydrates by synthetic group A carbohydrates and B-1 cell differentiation blockade: Novel concept in preventing antibody-mediated rejection in ABO-incompatible transplantation.","volume":"110","author":"Irei","year":"2007","journal-title":"Blood"},{"key":"R43-7-20210211","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/j.1399-3089.2006.00278.x","article-title":"Present status of ABO-incompatible kidney transplantation in Japan.","volume":"13","author":"Takahashi","year":"2006","journal-title":"Xenotransplantation"},{"key":"R44-7-20210211","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1111\/j.1399-3089.2006.00293.x","article-title":"ABO-incompatible kidney transplantation using antigen-specific immunoadsorption and rituximab: A single center experience.","volume":"13","author":"Donauer","year":"2006","journal-title":"Xenotransplantation"},{"key":"R45-7-20210211","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1097\/TP.0b013e3181726849","article-title":"ABO-incompatible kidney transplantation using antigen-specific immunoadsorption and rituximab: A 3-year follow-up.","volume":"85","author":"Genberg","year":"2008","journal-title":"Transplantation"},{"key":"R46-7-20210211","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1159\/000170813","article-title":"Evaluation of two different preconditioning regimens for ABO-incompatible living kidney donor transplantation. A comparison of splenectomy vs. rituximab-treated non-splenectomy preconditioning regimens.","volume":"162","author":"Tanabe","year":"2009","journal-title":"Contrib Nephrol"},{"key":"R47-7-20210211","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1111\/j.1600-6143.2005.01031.x","article-title":"ABO incompatible high-titer renal transplantation without splenectomy or anti-CD20 treatment.","volume":"5","author":"Segev","year":"2005","journal-title":"Am J Transplant"},{"key":"R48-7-20210211","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1111\/j.1600-6143.2008.02538.x","article-title":"Acute antibody-mediated rejection in living ABO-incompatible kidney transplantation: Long-term impact and risk factors.","volume":"9","author":"Toki","year":"2009","journal-title":"Am J Transplant"},{"key":"R49-7-20210211","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/j.1399-3089.2006.00296.x","article-title":"A series of surveys on assay for anti-A\/B antibody by Japanese ABO-incompatible Transplantation Committee.","volume":"13","author":"Kobayashi","year":"2006","journal-title":"Xenotransplantation"},{"issue":"12 suppl","key":"R50-7-20210211","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1097\/01.tp.0000296018.82857.ef","article-title":"Interinstitutional variation in the measurement of anti-A\/B antibodies: The Japanese ABO-Incompatible Transplantation Committee survey.","volume":"84","author":"Tanabe","year":"2007","journal-title":"Transplantation"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0b013e3181ba07ec","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T05:54:48Z","timestamp":1739426088000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00007890-200911270-00007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,11,27]]},"references-count":50,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0b013e3181ba07ec","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.1269957.737055","asserted-by":"object"}]},"ISSN":["0041-1337"],"issn-type":[{"value":"0041-1337","type":"print"}],"subject":[],"published":{"date-parts":[[2009,11,27]]}}}